Compare Johnson & Johnson (JNJ) vs Venture Global Inc. Class A common stock (VG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Venture Global Inc. Class A common stock — how do they compare? Johnson & Johnson trades at $256.34 (market cap $622.84B), while Venture Global Inc. Class A common stock trades at $13.22 (market cap $32.63B). The key difference: Johnson & Johnson is far larger — about 19.1× Venture Global Inc. Class A common stock's market cap, and Johnson & Johnson pays the higher dividend (2.07%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Venture Global Inc. Class A common stock for 0 Days on average.
| JNJ | VG | |
|---|---|---|
Market Cap | $622.84B | $32.63B |
Volume | 5,277,426 | 11,874,428 |
Sector | Health | Energy |
52-Week High | $278.43 | $17.53 |
52-Week Low | $186.00 | $5.92 |
Typical Hold Time | 129 Days | 0 Days |
Enterprise Value | $651.12B | $72.01B |
Dividend Yield | 2.07% | 1.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $256.48, up 0.67% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 21.48% net income margin and 25.74% ROE, though valuation metrics appear elevated with P/E of 29.98. Recent news highlights pipeline strength including Icotyde's potential $4.5B peak sales and Q3 earnings anticipation.
JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and elevated valuation. Analyst consensus targets $286.53 (11.7% upside) with 52.5% buy ratings. Key risks include biosimilar competition for Stelara and debt-to-asset ratio increase to 24.06% in 2025.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Venture Global Inc. Class A common stock
Venture Global develops, builds, and operates liquefied natural gas export facilities. Its projects connect U.S. natural gas supply with global LNG markets.
Read more on VG →
